DOPATREE
Preview
Open in TheBrain
DOPATREE
UNITED STATES GOVERNMENT ORGANIZATIONS / LISTINGS
US FOOD AND DRUG ADMINISTRATION (FDA)
DRUGS AND BIOLOGICS / RELATED / US
DRUG SAFETY AND BIOLOGIC SAFETY (PHARMACOVIGILANCE, PV, CLINICAL, POSTMARKETING, SERIOUS ADVERSE EVENT, SAE, IND, 7-DAY, 15-DAY, EXPEDITED, SIDE EFFECTS, ICSR, PSUR, LITERATURE, SURVEILLANCE, E2B, SAFETY REPORTING, DATA, MEDICATION)
DRUG SAFETY AND BIOLOGIC SAFETY / RELATED / INTL
TREATMENT-RELATED CONDITIONS-ALL (DRUG-RELATED, BIOLOGIC-RELATED, DEVICE-RELATED, TREATMENT EMERGENT ADVERSE EVENTS, TEAE, ADVERSE DRUG REACTIONS, SIDE EFFECTS, ALL TOXICITIES, TOXICITY, PRODUCT-RELATED, DRUG-INDUCED)
TREATMENT-RELATED CONDITIONS / LISTINGS
REBOUND EFFECT (DEPENDENCE, WITHDRAWAL, SYMPTOMS, RECURRENT EVENT AFTER TREATMENT DISCONTINUATION)
REBOUND EFFECT / MITIGATIONS
Parents
REBOUND EFFECT (DEPENDENCE, WITHDRAWAL, SYMPTOMS, RECURRENT EVENT AFTER TREATMENT DISCONTINUATION)
Children
MONITOR FOR SIGNS, EVALUATE, AND TREAT PROMPTLY
WITHDRAW PRODUCT GRADUALLY TO MINIMIZE THE RISK OF INCREASED FREQUENCY OR SEVERITY OF THE UNTREATED CONDITION